Company Logo

Pilaralisib

Pharmaceutical Information

Updated on Jan 14, 2019

View more like this | Visit SHIRLEY, NY | Contact BOC Smith
Pilaralisib, also known as XL147, is a methylbenzenesulfonamide derivative that reversibly inhibits class I PI3Ks (IC50s = 39, 36, 23, and 383 nM for p110α, δ, γ, and β, respectively), with potential antineoplastic activity.
Ordering Information
Image for Pilaralisib with ID of: 3103914
goodideazs, LLC is not affiliated with the authors of this post nor is it responsible for its content, the accuracy and authenticity of which should be independently verified.